Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals a...Show More
peer of
invested in
investor of
competitor of
Metrics
marketSTOCKS
msh_idCOM:ROYALTYPHARMA
localeus
websitehttps://www.royaltypharma.com/
ipo_date2020-06-16
primary_stock_msh_idNASDAQ:RPRX
source_ref55428a69-05b0-43c5-8a1f-46ee38ff92a3
products_or_servicesFunding solutions for biopharmaceutical royalties and partnerships.